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The aim of this study was to assess how varying the ratio of aqueous 0.8 M citric acid : 6 M polyacrylic acid
(PAA) (3 : 0, 1 or 3 byweight) aﬀected setting chemistry, mechanical properties and chlorhexidine di-acetate
(CHX) release of dicalcium phosphate – forming bone cements. Cement powder included b-tricalcium
phosphate (b-TCP) : monocalcium phosphate monohydrate (MCPM) : CHX at 1 : 1 : (0, 0.08 or 0.16)
molar ratio. Powder to liquid ratio was ﬁxed at 3 : 1 by weight. Chemical setting kinetics, reactive
intermediate formation and ﬁnal product homogeneity were assessed by ATR FTIR and Raman mapping.
Biaxial ﬂexural strength and modulus were determined after 24 hours setting plus 24 hours in water at
37 C and analysed using Weibull type equations. CHX release from 1 mm thick set discs was assessed
over 4 weeks using UV spectroscopy. FTIR demonstrated that CHX interaction with citric acid inhibited
formation of the reactive citrate/dicalcium phosphate intermediate complex that enables delay before
snap set. High CHX additionally increased strength variability. Upon partial citric acid substitution with
higher levels of PAA, delay before cement set was maintained. Monetite instead of brushite, however,
was formed in conjuction with more stable polyacrylate complexes. These formulations had much
improved strength but also greater modulus. CHX addition and interaction with PAA encouraged greater
brushite instead of monetite formation. These complex interactions enabled formulations with high drug
and PAA to have improved strength without increase in modulus. They also had low strength variability
and better (slower) controlled release of drug. These properties are beneﬁcial for cement use in a range
of orthopaedic and dental applications.1. Introduction
Calcium phosphate cements (CPCs) are widely used as bone
llers in orthopaedics.1–3 They also, however, have potential as
both jaw bone substitutes and tooth root lling materials in
dentistry. In these applications, CPCs may provide calcium and
phosphate ions for re-mineralisation of new bone or tooth
demineralised by periodontal or carious bacteria. In addition,
CPCs can provide controlled release of antibacterial agents
either by diﬀusion and/or upon cement degradation.4–7ering, UCL Eastman Dental Institute, 256
-mail: anne.young@ucl.ac.uk
astman Dental Institute, 256 Gray's Inn
iveristy of Birmingham, Birmingham, B4
iomaterials Division, Faculty of Dentistry,
of Saudi Arabia
try, Tanta University, Egypt
l Sultanah Aminah, 80100, Johor Bahru,
hemistry 2014CPCs are generally either hydroxyapatite (HA) or brushite –
forming. Brushite (dicalcium phosphate dihydrate) – forming
formulations can be produced by mixing mono and tri calcium
phosphates (MCPM and TCP) with water. The chemical setting
reaction is given by:Ca(H2PO4)2$H2O + b-Ca3(PO4)2 + 7H2O/ 4CaHPO4$2H2O (1)
Early retardation of this reaction is required to provide suﬃ-
cient mixing/working time. Subsequent rapid snap set aer
application, however, is benecial for preventing leakage from the
site of application. In brushite cements, working time may be
enhanced through use of calcium chelating molecules such as
citric acid. Optimisation of setting retardant levels enables max-
imisation of powder content, thereby reducing porosity and
increasing strength. Too much citric acid, however, has been
found to cause formation of monetite (anhydrous dicalcium
phosphate) instead of brushite.2 As water is not bound in mone-
tite, formation of this dicalcium phosphate eﬀectively decreases
the nal solid to liquid (or pore) ratio and thereby reduces
strength.8J. Mater. Chem. B, 2014, 2, 1673–1680 | 1673
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View Article OnlineDespite signicant improvement in optimised CPC cement
compressive strengths in the past 10 years, relatively few studies
have considered tensile or exural properties. The low values
observed for these strengths, however, prevent CPC use in many
higher load bearing applications.9 Moreover, increase in
strength is generally associated with a rise in modulus, brittle
fracture and poor resilience.10 With brittle CPCs the range of
strengths for a given formulation can also be wide.
Many studies have considered release of antibiotics from
CPCs. Antibiotic resistance, however, is of growing concern
particularly in dental applications. The antibacterial chlorhex-
idine diacetate [(CH2)3NH(C(]NH)NH)2C6H4Cl]2$2CH3COOH
(CHX) has minimum inhibitory concentrations for many bacteria
that are comparable with antibiotics but the reported bacterial
resistance is lower.11,12 It is widely used in dentistry for plaque
control. Commercial examples in which it is employed include
Corsodyl™ and PerioChip®.13,14 Release of chlorhexidine from
brushite cement has previously been investigated.5 Chlorhexidine
and other drug release from CPCs, however, can be too rapid for
prolonged benet.14 Antibiotics can additionally aﬀect setting and
mechanical properties.4–7 Chlorhexidine was previously found to
have only minor eﬀects on brushite setting kinetics but its eﬀects
on mechanical properties were not reported.5
Polyacrylic acid (PAA) has been used in various implantable
cements for over 50 years. It is a main component of commer-
cial glass ionomer cements employed for both tooth and bone
repair.15,16 Early CPC studies demonstrated that PAA can
interact with antibiotic gentamicin and slow its release from
brushite cements.7 PAA has also been shown to enhance the
strength of CPC.17 The aim of this new study is therefore to
address how citric acid replacement by PAA aﬀects setting
kinetics, nal chemistry, exural strength and CHX release of a
TCP/MCPM cement. It will also cover, if PAA can increase
cement exural strength without enhancing modulus or
causing a broadening of strength values.2. Materials and methods
Cements were prepared using aqueous polyacrylic and/or citric
acid, mono and tricalcium phosphate and chlorhexidine diac-
etate powder. FTIR and Raman spectroscopy were used to assess
setting kinetics and nal composition of set cements respec-
tively. Biaxial exural strength and modulus were assessedTable 1 Cement codes and compositions
Formulation
code
MCPM
powder (g)
b-TCP
powder (g)
C0P0 1.0 1.23
C0P3 1.0 1.23
C0P6 1.0 1.23
C6P0 1.0 1.23
C6P3 1.0 1.23
C6P6 1.0 1.23
C12P0 1.0 1.23
C12P3 1.0 1.23
C12P6 1.0 1.23
1674 | J. Mater. Chem. B, 2014, 2, 1673–1680through two-parameter Weibull distribution analysis. CHX
release proles in water were also determined.2.1 Materials
b-Tricalcium phosphate (TCP) was prepared as previously
described18,19 (median particle size of 11 micron). Monocalcium
phosphate monohydrate (MCPM) powder (Rhodia, Birming-
ham, UK) (particle size 62 mm20), chlorhexidine diacetate salt
hydrate (CHX) and citric acid powders (ACS grade Sigma-
Aldrich, UK) were employed. 0.8 M (15 wt%) aqueous citric
acid solution (CA) was prepared. 6 M (43 wt%) aqueous pol-
yacrylic acid (PAA) solution was obtained from GC America Inc
(Fuji IX liquid). MALDI-TOF mass spectrometry indicated a
number average PAA molecular weight of 2100 g mol1.2.2 Cement and disc preparation
Fluid pastes were obtained by mixing powder : liquid in a
weight ratio of 3 : 1. Powders contained molar ratios of
MCPM : TCP : CHX of 1 : 1 : (0, 0.08 or 0.16). The higher level of
CHX is the maximum that previous studies showed can be
included in a basic brushite cement without signicantly
increasing reaction rate.5 Liquids consisted of 0.8 M CA : 6 M
PAA in weight ratios 3 : (0, 1 or 3). Formulations were coded as
CxPy where x and y are approximate weight percentages of CHX
(0, 6 or 12 wt%) and PAA (0, 3 and 6 wt%) in the cement
(see Table 1).
For exural testing and drug release studies, cement discs of
10 mm diameter and 1 mm thickness were prepared using
metal rings as moulds. The samples were sealed in the rings
using acetate sheet on both sides and le to fully set at 37 C for
24 hours before specimen removal.2.3 Setting chemistry analysis using FTIR
Cement setting reactions were assessed using a Perkin Elmer
Series 2000 FTIR spectrometer (Beaconseld, UK). Approxi-
mately 0.35 g of each paste was placed on the diamond of a
golden gate ATR attachment (Specac) at 37 C. Cement spectra
were generated between 700 and 4000 cm1 with a resolution of
8 cm1. These were collected every 6 s from within 30 s from the
start of cement mixing for 1 hour and converted into proles
using Timebase soware (Perkin Elmer).CHX
powder (g)
800 mM citric
acid (g)
PAA
solution (g)
0 0.74 0
0 0.55 0.19
0 0.37 0.37
0.2 0.8 0
0.2 0.6 0.2
0.2 0.4 0.4
0.4 0.88 0
0.4 0.66 0.22
0.4 0.44 0.44
This journal is © The Royal Society of Chemistry 2014
Paper Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
Fe
br
ua
ry
 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
1/
07
/2
01
4 
15
:3
3:
24
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineDiﬀerence spectra were calculated by subtracting the rst
spectrum at 100 s from that at later times. These are charac-
teristic for diﬀerent chemical reactions and for a simple single
reaction with no intermediate products are independent of
time. Characteristic diﬀerence spectra for setting brushite and
glass ionomer cements can be found in ref. 2 and 16 respec-
tively. From absorbance proles, absorbance change DA,
maximum absorbance change, DAmax, and apparent fractional
reaction extent, z were calculated at various wavenumbers.
These are dened by8
z ¼ DA
DAmax
¼ At  A0
Af  A0 (2)
A0, At and Af are absorbance at time 0, t and nally. A0 and Af
were calculated by linear extrapolation of early absorbance
versus time, or late absorbance versus inverse time, to zero.
Additionally, the time for half reaction, t0.5 dened as the time
at which reaction extent equalled 0.5, was calculated in seconds.2.4 Raman spectra of set cements
Cements set at 37 C were examined using Raman mapping. A
LabRam spectrometer (Horiba Jobin Yvon, Stanmore, UK),
equipped with a 633 nm laser, grating set at 1800, 50 objective
and wavenumber range of 700 to 1650 cm1 was used. For each
specimen, spectra were obtained in 3 mapping areas. Each area
was 50  50 mm and spectra were obtained in 10 mm steps
providing 25 spectra per area. Run time and number were
selected to ensure suﬃcient peak intensity above background
and noise. Peak assignments were achieved by comparison with
spectra of pure b-TCP, MCPM, brushite, monetite, CHX and PAA
and LabRam soware (Horiba Jobin Yvon).5 Ratios of diﬀerent
components in a set formulation were estimated from the
number of spectra containing peaks for a given chemical
divided by the total number of spectra generated.2.5 Biaxial exural properties
For strength and modulus studies, a “ball on ring” biaxial
exural test method was employed. Twenty discs for each
formulation were prepared. Each disc was hydrated in 10 ml
distilled water at 37 C for 24 hours before testing. Sample
thickness t, was measured at three diﬀerent points and aver-
aged. Each sample was then placed on a knife edge ring support
(radius a¼ 4mm) and loaded using a spherical tip in an Instron
4505 Universal Testing Machine. The strength and modulus
were calculated using eqn (3) and (4)21
s ¼ P
t2

ð1þ nÞ

0:485 ln

a
t

þ 0:52

þ 0:48

(3)
and
E ¼

dP
du

0:5024a2
t3

(4)
where s – strength (MPa), P – force (N), u – central specimen
displacement (mm), a – support radius (mm), t – thickness of
the disc (mm), n – Poisson's ratio and was taken as 0.3,22,23 E –
modulus (GPa).This journal is © The Royal Society of Chemistry 2014Strength and modulus distributions were tted to a Weibull
expression:24
Pf ¼ 1  exp(s/sq)m (5)
where m –Weibull shape parameter, Pf – probability of fracture,
s – exural strength or modulus of each specimen, sq – Weibull
scale parameter.
When s ¼ sq, Pf ¼ 63.2%. Pf was dened as (i  0.5)/n, where
n is the number of specimens and i is the rank of a specimen in
a list when strength or modulus are ordered from lowest to
highest values. Taking double logs of eqn (5) gives:
lnln[1/(1  Pf)] ¼ m ln s  m ln sq (6)
Weibull parameters and quality of t were therefore calcu-
lated from the slope and intercept and R2 values of linear
regression of the le hand side of eqn (6) plotted versus ln s.
One-way analysis of variance (ANOVA) and t-test at a signi-
cance level of 95% were utilised to identify if properties were
signicantly diﬀerent between formulations.2.6 Chlorhexidine release
To quantify CHX release, fully set discs (10 mm diameter and
1 mm thickness) of each composition (n ¼ 3) were weighed and
immersed in 10 ml of distilled water (at 37 C) within sterile tubes.
At time points of 1, 2, 4, 8, 24, 72, 168, 336 and 672 hours the
specimens were removed and replaced in fresh distilled water. UV
spectra of storage solutions were obtained between 200 and
400 nm using a Unicam UV 500 spectrometer (Thermo Spectronic,
UK). These were compared with calibration graphs created in the
same range for solutions of known concentration to ensure CHX
was the only component causing absorbance. The CHX peak at
255 nm was then used to calculate the cumulative percentage
release at a given time from each specimen.5Condence interval at
95% for CHX release was calculated from standard deviation (SD)
using
CI ¼ 2SDﬃﬃﬃ
n
p (7)
3. Results
3.1 FTIR kinetic investigations: diﬀerence spectra
Example nal FTIR diﬀerence spectra, obtained by subtracting
the spectra at 100 s from those at 3600 s, are presented in Fig. 1.
Their peaks and trough assignments are listed in Table 2. These
were, for most samples, consistent with a brushite (dicalcium
phosphate dihydrate, DCPD) cement reaction. Brushite cement
diﬀerence spectra have peaks due to both dicalcium phosphate
formation (DCP) (between 800 and 1200 cm1) and water
binding (1640 and 3300 cm1). The two exceptions were C0P3
and C0P6. Diﬀerence spectra of these two formulations had
several peaks consistent with DCP formation but no water
binding peaks or characteristic DCPD peak at 985 cm1. This
suggests monetite instead of brushite formation. These excep-
tions also gave broad diﬀerence spectra bands (840, 1380 andJ. Mater. Chem. B, 2014, 2, 1673–1680 | 1675
Fig. 1 Example FTIR diﬀerence spectra at 3600 s for cements setting
at 37 C.
Table 2 Assignment of FTIR diﬀerence spectra peaks and troughs
Wavenumber
(cm1) Peak/trough Dominant cause
Dominant
assignments
3540 Peak
sharpening
Water binding in
DCPD
O–H stretch
3480 Peak
sharpening
Water binding in
DCPD
O–H stretch
3280 Peak
sharpening
Water binding in
DCPD
O–H stretch
3160 Peak
sharpening
Water binding in
DCPD
O–H stretch
3000 Broad trough Acid neutralisation O–H loss
1650 Peak
sharpening
Water binding in
DCPD
O–H stretch
1570 Broad band Citrate Asymmetric COO
stretch
1520 Broad band Polyacrylate Asymmetric COO
stretch
1440 Broad band Citrate Symmetric COO
stretch
1380 Broad band Polyacrylate Symmetric COO
stretch
1250 Trough Acid neutralisation C–O stretch loss
1230 Trough MCPM loss P–O stretch loss
1210 Sharp peak DCP P–O stretch
1125 Sharp peak DCP P–O stretch
1070 Sharp trough MCPM loss P–O stretch loss
1055 Sharp peak DCP P–O stretch
1010 Sharp trough TCP loss P–O stretch loss
985 Sharp peak DCPD P–O stretch
960 Trough MCPM loss P–O stretch
880 Broad band Citrate COO
870 Sharp peak DCP P–O(H)
840 Broad band Polyacrylate COO
780 Broad band DCPD Water libration
Fig. 2 FTIR parameters obtained using proﬁles at 980 cm1 and
1050 cm1 for cements with diﬀerent PAA and CHX weight percent-
ages (error bars indicate diﬀerence upon repetition). (a): Maximum
absorbance change, DAmax, (b): time for half maximum absorbance
change, t0.5 (s).
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View Article Online1520 cm1) typically observed upon neutralisation of polyacrylic
acid in a glass ionomer cement.
3.2 FTIR kinetic investigations: absorbance proles
DAmax values calculated using absorbance changes at 1050 and
980 cm1 are provided for all formulations in Fig. 2a. Repetition
indicated good reproducibility for all samples except C12P0. For
most formulations, DAmax values were roughly comparable at1676 | J. Mater. Chem. B, 2014, 2, 1673–1680these two wavenumbers but both declined upon increasing
PAA. DAmax values for C0P3 and C0P6, however, were particu-
larly low. They were also anomalous in that the absorbance
change at 1050 cm1 was approximately double that at
980 cm1 instead of comparable. This was consistent with
formation of monetite instead of brushite.
Time for half reaction t0.5, calculated from proles at
1050 cm1 gave comparable results to those from 980 cm1
proles (see Fig. 2b). Addition of CHX had negligible eﬀect on
time of half reaction when PAA was absent, but caused up to
30% reduction of t0.5 when polymer was present. Moreover,
partial replacement of citric acid by a more concentrated PAA
solution enabled retardation of the setting reaction to be
maintained and in some cases (particularly C0P3, C0P6 and
C6P3) enhanced.
Fig. 3a provides examples of reaction extent versus normal-
ised time. These show that with all formulations there was a
delay before rapid reaction. Citric acid replacement by PAA had
negligible eﬀect on the shape of these proles and the inhibi-
tion period was approximately half the half-life. Addition of
CHX, however, could cause the reaction to be less sharp and the
delay before reaction to be a smaller fraction of the reaction
half-life.
For most samples, during early stages of the reaction a small
temporary increase in absorbance at 1400 cm1, consistent with
the formation of reactive intermediate citrate complexes, was
observed (see for example Fig. 3b). Addition of CHX decreased
the time over which this change was observed. Conversely with
C0P3 and C0P6, absorbance increase at 1400 cm1 was not lost
during later stages of the reaction. This suggests formation of a
more stable calcium polyacrylate complex. Comparison ofThis journal is © The Royal Society of Chemistry 2014
Fig. 3 (a) Reaction extent z at 1050 cm1 and (b) absorbance change
DA at 1400 cm1. In both cases t0.5 was calculated from the 1050 cm
1
absorbance proﬁle.
Table 3 Assignment of Raman spectra peaks
Wavenumber (cm1) Component Peak type
890 DCPD Sharp weak singlet
900 DCP Broad weak peak
906 MCPM Sharp strong doublet
955 TCP Sharp strong doublet
990 DCPD Sharp strong singlet
990 DCP Broad weak peak
1095 CHX solid Sharp strong singlet
1180 CHX solid Sharp strong singlet
1250 CHX solid Sharp strong singlet
1290 CHX solid Sharp strong doublet
1600 CHX solid Sharp strong singlet
Paper Journal of Materials Chemistry B
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View Article OnlineFig. 3a and b indicates polyacrylate complex forms at the same
time as monetite precipitation. Conversely the reactive inter-
mediate citrate complexes form before brushite precipitation.3.3 Raman spectroscopy
Average Raman spectra. Average Raman spectra of selected
formulations are illustrated in Fig. 4 and peak assignments
listed in Table 3. Average spectra of most formulations gave a
strong distinctive brushite peak at 987 cm1. In contrast, with
C0P3 and C0P6 this peak was much broadened and more
comparable with a monetite Raman spectrum. Furthermore, in
C0P6 there were organic polymer peaks around 1400–1500 cm1
consistent with calcium polyacrylate. In CHX containing
formulations, any polymer peaks were masked in average
spectra by the various sharp, strong and overlapping peaks of
the drug.Fig. 4 Average Raman spectra of set cements.
This journal is © The Royal Society of Chemistry 2014Raman mapping. Raman mapping analysis of set cements
indicated >90% conversion of MCPM and TCP in all formula-
tions except C6P0 and C12P0 which had 10 and 25% TCP
remaining respectively. C0P0, C6P0, C12P0 and C12P3 con-
tained brushite but no monetite. Conversely, C0P3 and C0P6
contained monetite but no brushite. The ratio of brush-
ite : monetite decreased in the order C6P3 (3 : 3) < C12P6 (2 : 3)
< C6P6 (1 : 3). In other words, polymer encourages monetite but
CHX brushite formation.3.4 Flexural properties of cements
Probability of fracture was plotted versus biaxial strength (Fig. 5)
and associatedWeibull parameters calculated (Table 4) for selected
formulations. The high R2 values indicated good agreementFig. 5 Probability of fracture versus biaxial ﬂexural strength of selected
cements. Line indicates sq.
Table 4 Weibull scale sq and shape m parameters obtained upon
ﬁtting eqn (6) to biaxial ﬂexural strength and modulus data
Weibull
parameters C0P0 C0P6 C12P0 C12P6
Flexural strength (MPa) sq 4.8 7.3 4.8 8.5
m 8.8 6.8 3.4 5.5
R2 0.96 0.93 0.95 0.96
Flexural modulus (GPa) sq 0.45 0.63 0.42 0.49
m 4.7 3.9 1.9 4.4
R2 0.91 0.96 0.84 0.93
J. Mater. Chem. B, 2014, 2, 1673–1680 | 1677
Fig. 6 Cumulative CHX release from cements in water (note: double
log scale).
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View Article Onlinebetween the theoretical expression and strength data for all mate-
rials. The Weibull strength scale parameter, sq, increased signi-
cantly (p < 0.05) upon addition of PAA but was not aﬀected by CHX.
Addition of CHX also reduced the shape parameter,m, indicating a
broadened distribution of strengths. The combination of PAA with
CHX in C12P6 could partially overcome this problem.
R2 values indicated the Weibull expression tted modulus
data of C12P0 less well (see Table 4). As the modulus shape
parameter was also particularly low for C12P0 it is likely that
these samples were less homogeneous. Addition of PAA alone
signicantly (p < 0.05) increased the modulus but with C12P6
lower modulus and higher shape parameter (i.e. better homo-
geneity) were maintained.
3.5 CHX release from cements
The CHX release proles in water are provided in Fig. 6. Release
rate from C6P0 and C12P0 without polymer in the rst 72 hours
was >50% and as expected for a rapid diﬀusion controlled
process. By 672 hours (28 days) all the CHX had been released.
Formulations with PAA have some release at short times but
much of the drug remains trapped consistent with strong
interaction between CHX and PAA. C12P6 releases more CHX
than other formulations with both PAA and drug. Neither this
formulation nor C6P3 exhibited signicant release aer
72 hours. For the other formulations (C6P6 and C6P3)
continuing release was detectable over 672 hours (28 days) but
this was continually slowing. Note – both axes in Fig. 6 were
plotted in logarithmic scale to illustrate full range of data for a
prolonged period of time.
4. Discussion
This study has quantied the eﬀects of partial substitution of
0.8 M citric acid by 6 M PAA and varying CHX levels on setting
rates, nal composition, mechanical properties, and release
kinetics of CHX from a dicalcium phosphate forming bone
cement. Equimolar MCPM : TCP was used as required by eqn
(1) for complete reaction. The powder to liquid ratio was close to
the highest level possible whilst achieving a uid paste to
maximize strength. The level of citric acid was based upon the1678 | J. Mater. Chem. B, 2014, 2, 1673–1680amount previous studies have shown are required to ensure
suﬃcient delay for clinical placement before set and optimal
mechanical properties.2 6 M PAA was close to the aqueous
solubility limit of this acid but was suﬃcient to have compa-
rable eﬀect on setting to 0.8 M citric acid. The molecular weight
of this PAA was kept low as preliminary studies showed higher
molecular weight polymers were less water soluble and unable
to act as eﬀective setting retardants.4.1 Setting kinetics and nal chemistry
Setting rates of the control brushite cements (C0P0) in this
study were comparable with those observed previously.5 In the
controls, citric acid acted as a retardant by chelating with
calcium. This interaction provided a period of restricted reac-
tion upon initial mixing and is required for ease of clinical
placement. FTIR has previously demonstrated early formation
of citric acid/dicalcium phosphate complexes in brushite
cements.2 These species, however, are reactive intermediates
and diﬃcult to detect unless the citric acid concentration is
high. High CHX concentrations in both previous work5 and this
new study reduced the inhibition periods possibly due to its
interacting with the citric acid retardants. This new study has
also demonstrated CHX can detrimentally broaden the setting
time. Raman mapping also conrmed CHX could prevent full
conversion of TCP presumably by reducing acidity.
The above studies demonstrate that citric acid (0.8 M) has to
be replaced by polyacrylic acid of much higher concentration
(6 M) to provide comparable working times particularly with
higher levels of CHX also present. Higher PAA concentration
may be required due to slower diﬀusion of the larger polymeric
molecules. This would additionally explain why PAA of greater
molecular weight could not retard the setting reaction (data not
shown). The simultaneous formation of monetite and calcium
polyacrylate peaks in FTIR studies of C0P3 and C0P6 suggests
these products may form a stable complex together. The greater
complex stability compared within C0P0 may be a consequence
of the higher levels of PAA compared with citric acid. Addi-
tionally, however, the large number of chelating groups per
molecule on PAA would inhibit breakdown of the complexes
once formed. Interaction between PAA and CHX reduced the
formation of these stable complexes enabling brushite to form
instead of monetite.
In the cements CxPy the ratio of MCPM : TCP was xed at
1 : 1. Eqn (1) indicates 1 mole of MCPM and TCP will give 4
moles of brushite but this will require 7 moles of water. Relative
to MCPM, average moles of citric acid were 0.16, 0.12 or 0.08,
PAA 0, 0.3 or 0.6 and water 10, 9 or 8 for y¼ 0, 3 or 6 respectively.
Trivalent citric acid at its highest level (0.16 moles per mole
MCPM) would require 0.24 moles of divalent calcium to form
citrate. PAA at its highest level (0.6 moles per mole MCPM)
requires 0.3 moles of calcium to enable full calcium polyacrylate
formation. The maximum levels of calcium required to form
citrate or polyacrylate salts would therefore be less than 10% of
that in any of the cements (4 moles Ca per mole MCPM). These
acids are therefore not at suﬃcient levels to ultimately inhibit
dicalcium phosphate precipitation.This journal is © The Royal Society of Chemistry 2014
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View Article OnlineIn all the cements there is a slight excess of water for
brushite formation. For calcium polyacrylate to also form,
previous studies on glass ionomer cements have suggested a
minimum of 5 moles of water per mole of PAA are required.15 In
C0P6, therefore more than 3 moles of water might be required
to enable PAA to be fully neutralised leaving less than 5 moles
which is insuﬃcient for full brushite formation. This could
explain formation of monetite.
Moles of CHX relative to MCPM were 0, 0.08 and 0.16 for x ¼
0, 6 and 12 respectively. Therefore, as CHX is dibasic, in C12P3
the ratio of acidic PAA to basic CHX groups will be 0.30 : 0.32. If
these components fully interact without binding water, this
would explain why only brushite and no monetite form. This
would also explain why in C6P3, where CHX is halved, approx-
imately equal brushite and monetite are formed. In C6P6, with
both CHX halved and PAA doubled the level of monetite is
3 times that of brushite. With C12P6 there was slightly more
monetite than brushite which might suggest that not all the
CHX in this case has interacted with PAA. This could help
explain higher percentage CHX release in this formulation
compared with the other PAA containing cements.4.2 Strength and modulus
The theory behind the Weibull expression is based on the
premise that specimen-to-specimen variability of strength is an
intrinsic property of the cement, reecting its aw population. A
material under load may break from a sharp aw but not from
micro-cracks or large pores. Each aw type has its own distri-
bution. Poor tting of a simple Weibull expression can be
indicative of fracture resulting frommultiple aw types.24 As the
Weibull equation described ts the strength distributions well
in the above cements, it suggests that only one type of aw is
primarily responsible for material failure. The increase in
strength with PAA addition (C0P6) may be a consequence of
polymer/monetite complex formation. Usually formation of
monetite is associated with a decrease in strength due to greater
porosity and less binding of water in the cement structure.8 In
this study, however, the polymer is occupying the pores and
binding the water. In C12P6 the polymer may again be lling
holes but greater brushite formation instead of entirely mone-
tite could further be enhancing the strength.
The broadened strength distribution upon adding CHX
without PAA suggests that the size distribution of aws was
widened. This could be a consequence of reduced TCP conver-
sion and poorer mixing/larger more loosely connected crystals
due to faster setting.25 Furthermore, fast CHX release could have
increased the number of aws. Moreover, the inability of the
Weibull equation to t modulus data provides further evidence
for poor material homogeneity in C12P0.
The highest compressive strength reported for brushite
cements has been 53 MPa.26 Tensile strengths however are an
order of magnitude lower and further reduced upon cement
placement in water.25 Flexural strengths are generally more
comparable with tensile than compressive strengths. The ex-
ural strengths obtained in this study, particularly with high
PAA, are therefore greater than expected from previous work.This journal is © The Royal Society of Chemistry 2014The combination of PAA and CHX also benecially reduces
modulus whilst enabling strength maintenance which will
increase resilience (area under stress–strain curve).
To enable CEmarking of newmaterials, expensive in vitro and
in vivo studies demonstrating benet are required. Alternatively,
suﬃcient evidence of previous application of similar materials/
material components in man is required. TCP/MCPM cements
have been commercialised by various companies (e.g. ChronOs
inject®, PD VitalOs®) for bone lling due to their injectability,
biocompatibility degradability and transformation into brushite
and then hydroxyapatite in vivo.25,31,32 Additionally, although PAA
has been commercially appliedmore in dental applications it has
also been employed previously in bone repair.33
A further potential application for the new materials is bone
fracture stabilisation. A recent in vivo study showed, however, that
the basic brushite cement described in this paper,may be too rigid
for this application. Production of more exible cement, by total
replacement of the aqueous phase of the brushite cement with a
polymer, solved this issue.32 Furthermore, the study suggested that
formation of polyacidic groups (as in polyacrylic acid) could enable
“self-repair” of the cement–bone interface as the bone remodels.324.3 Drug release
Raman and UV spectroscopy respectively, conrmed that CHX
was entrapped within and subsequently released from the
brushite cements without change in chemical structure. CHX is
known to be eﬀective under acidic conditions in the mouth. The
presence of citric or polyacrylic acid was therefore not expected
to detrimentally aﬀect the action of this antibacterial. A further
advantage of this drug is its ability to bind to oral tissues
enabling more prolonged benet.14
CHX release from formulations without PAA (C6P0 and
C12P0) was rapid and comparable with previous studies.27 Linear
release versus square root of time and none dependence upon
concentration is as expected upon diﬀusion controlled drug
release from a porous cement. Conversely, CHX release from
formulations C6P3, C6P6 and C12P3 was severely inhibited and
possibly, for some applications, too much to provide early anti-
bacterial action. With C12P6, however, the moderate early CHX
release could be more benecial. Competition between CHX and
brushite for complexation with PAA would explain the complex
dependence of CHX release upon both cement composition and
time. The release of CHX from C12P6 at later times is limited. It
should be noted, however, that brushite cements degrade more
rapidly in vivo than in vitro due to the action of cells and
enzymes.28–30 Later time release of CHX is likely therefore to be
faster in vivo as the surrounding brushite matrix is lost.
Further potential applications of the new cements are for
treatment of perioimplantitis and periodontal disease. In both,
bacteria cause recession of the jaw bone. Perioimplantitis is a
growing problem that is diﬃcult to treat and results in loosing
of tooth implants. The new antibacterial brushite cements
could be injected around the implant, treat the disease and
provide ions to help the jaw repair. One commercial product for
periodontal disease is PerioChip®. This contains 37 vol% CHX
in a degradable polymer lm. One problem, however, isJ. Mater. Chem. B, 2014, 2, 1673–1680 | 1679
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View Article Onlinediﬃculty in placement and movement from the site of appli-
cation. An in vivo study showed this material releases approxi-
mately 40% of its CHX within 24 h. The remainder is released
over the next 7 days.14 Long term antibacterial action is there-
fore limited. Furthermore, the concentration of drug initially
found in the periodontal pocket (1000 ppm) is much higher
than minimum inhibitory concentrations (MIC) for periodontal
bacterial and therefore in excess of what is required.
In comparison, the injectability of the above new brushite
cements makes them easier to place and aer set, less likely to
move. As the brushite cement density is2.2 g cm3, those with
high CHX contain27 vol% of this drug. The above new release
studies therefore suggest that C12P6 of comparable dimensions
will release suﬃcient CHX in the rst 24 hours to provide levels
of antibacterial approximately 6 times lower than PerioChip®.
This should be suﬃcient for eﬀective early antibacterial action.
In vivo, greater dissolution of C12P6 should enable higher levels
of drug to be released than observed in water. This would help
maintenance of drug concentration at higher levels than with
PerioChip® at later times provided the drug is not washed out
of the periodontal pocket too quickly. The level of wash out
unfortunately increases as the level of disease progresses. For
more extensive disease, more of the material would therefore
need to be employed. A further advantage of the brushite
cements, however, is that they would additionally provide
calcium and phosphate ions to aid regrowth of the jaw bone.
5. Conclusions
6 M PAA can partially replace 0.8 M citric acid as a setting
retardant for the above dicalcium phosphate – forming
cements. These PAA levels can cause monetite instead of
brushite precipitation and formation of stable polyacrylate
complexes. CHX interaction with citric acid or PAA can reduce
the sharpness of the setting reaction. CHX can also prevent full
reaction of TCP and through reducing homogeneity broaden
the range of cement exural strengths. PAA addition reduced
this problem. CHX interaction with PAA also encouraged
brushite instead of monetite formation. These interactions
enabled the C12P6 formulation to have relatively low modulus,
higher average strength, and more controlled release of CHX.
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